Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.54M | -4.14M | -3.09M | -1.64M | -237.90K |
| Total Depreciation and Amortization | 1.30M | 1.28M | 1.24M | 1.25M | 1.12M |
| Total Amortization of Deferred Charges | 50.30K | 50.30K | 50.30K | 25.30K | 102.10K |
| Total Other Non-Cash Items | 884.60K | 876.40K | 837.60K | 818.60K | 805.40K |
| Change in Net Operating Assets | -1.06M | -1.48M | -1.55M | -526.20K | -1.36M |
| Cash from Operations | -2.37M | -3.42M | -2.50M | -70.50K | 430.10K |
| Capital Expenditure | -431.10K | -537.20K | -545.80K | -568.70K | -625.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -431.10K | -537.20K | -545.80K | -568.70K | -625.00K |
| Total Debt Issued | 359.30K | 359.30K | 359.30K | 359.30K | -- |
| Total Debt Repaid | -635.00K | -439.10K | -2.22M | -2.23M | -2.23M |
| Issuance of Common Stock | 0.00 | 0.00 | 2.74M | 2.82M | 2.82M |
| Repurchase of Common Stock | -778.80K | -836.30K | -1.39M | -1.73M | -1.84M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -763.20K | -663.20K | -371.60K | -558.40K | -898.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -3.56M | -4.62M | -3.42M | -1.20M | -1.09M |